Prévisions

Aucune donnée d'analyste n'est disponible pour cette entreprise.

Actualités Accéder au fil d'actualités

Swiss stock market falls after previous-day rally; Swiss Re drags SMI lower

The Swiss benchmark index SMI lost 1.1% to 13,135 points after profit-taking spread across Europe in the afternoon. Swiss Re fell 3.2% after RBC criticized the quality of first-quarter results as well as sales and pricing trends. Roche confirmed the takeover of PathAI for up to 1.05 billion USD and its shares dropped 1.1%, while AMS-Osram rose by more than 29% following an AI contract. Novartis and Nestlé fell about 2% and 1.4% respectively; trading volume was 25.43 million shares. » Plus sur finanzen.net
Munich Re under pressure after weak reaction to Swiss Re results, report on May 12 in focus

Munich Re's stock came under pressure after Swiss Re fell sharply following Q1 results, even though net profit was surprisingly strong. Analysts see early signs of a cooling reinsurance market, but Munich Re remains profitable and aims for a 2026 profit target of €6.3 billion. Investors will pay particular attention to large losses, pricing dynamics in reinsurance and comments on the annual target when the quarterly report is released on May 12. » Plus sur deraktionaer.de
Swiss Re posts first-quarter profit of $1.5bn and ROE of 23.6%

Swiss Re reports a group profit of $1.5bn for Q1 2026 (+19%) and a return on equity of 23.6%, driven by contributions from all business units, low natural catastrophe losses and a strong investment result. P&C Re posted a profit of $754m with a loss and expense ratio of 79.5%, Corporate Solutions $262m and L&H Re $491m. The investment return was 4.6% and the estimated SST ratio stood at 252%. Swiss Re highlights disciplined underwriting, cycle management and cost efficiency in a challenging market environment. » Plus sur de.investing.com